| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
135,699 |
124,303 |
$11.67M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
58,191 |
50,775 |
$4.54M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
26,163 |
24,732 |
$2.17M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
10,676 |
10,090 |
$1.10M |
| 80053 |
Comprehensive metabolic panel |
20,234 |
16,876 |
$785K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,426 |
5,507 |
$753K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,639 |
4,208 |
$662K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14,378 |
11,693 |
$610K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,962 |
6,739 |
$599K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,219 |
1,982 |
$399K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,603 |
2,362 |
$379K |
| 10060 |
|
1,879 |
1,761 |
$289K |
| 81003 |
|
29,642 |
26,943 |
$262K |
| 59025 |
Fetal non-stress test |
5,115 |
3,818 |
$238K |
| 84702 |
|
4,643 |
3,664 |
$217K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,852 |
4,168 |
$198K |
| 76818 |
|
2,670 |
1,311 |
$172K |
| 71046 |
Radiologic examination, chest; 2 views |
13,460 |
12,473 |
$164K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,423 |
1,311 |
$143K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,882 |
1,770 |
$132K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,597 |
1,501 |
$131K |
| 12001 |
|
1,103 |
1,050 |
$129K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,241 |
471 |
$123K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,883 |
10,358 |
$106K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,718 |
2,581 |
$101K |
| 81001 |
|
8,826 |
7,852 |
$98K |
| 87210 |
|
6,008 |
5,614 |
$97K |
| 87070 |
|
3,973 |
3,790 |
$95K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,779 |
11,497 |
$93K |
| 86850 |
|
1,116 |
969 |
$86K |
| 36415 |
Collection of venous blood by venipuncture |
3,332 |
2,163 |
$85K |
| 85027 |
|
37,165 |
29,473 |
$84K |
| 12011 |
|
796 |
748 |
$83K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,345 |
2,138 |
$78K |
| 81025 |
|
30,516 |
27,791 |
$75K |
| 84112 |
|
529 |
479 |
$74K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,169 |
1,870 |
$73K |
| 87430 |
|
8,101 |
7,737 |
$61K |
| 80305 |
|
2,194 |
1,981 |
$61K |
| G0378 |
Hospital observation service, per hour |
4,485 |
2,612 |
$60K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,285 |
1,877 |
$56K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,976 |
18,028 |
$56K |
| 73610 |
|
1,946 |
1,795 |
$55K |
| 73130 |
|
1,871 |
1,721 |
$53K |
| 71045 |
Radiologic examination, chest; single view |
10,079 |
8,629 |
$50K |
| 73630 |
|
2,089 |
1,917 |
$48K |
| 82565 |
|
674 |
554 |
$48K |
| A9270 |
Non-covered item or service |
11,551 |
3,346 |
$45K |
| 73564 |
|
1,799 |
1,633 |
$44K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
8,279 |
7,740 |
$43K |
| 76801 |
|
3,908 |
3,187 |
$42K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,326 |
4,921 |
$41K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,946 |
3,582 |
$39K |
| 12002 |
|
364 |
340 |
$39K |
| 73030 |
|
1,594 |
1,393 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
17,347 |
13,902 |
$31K |
| 87077 |
|
1,842 |
1,651 |
$29K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,450 |
1,147 |
$28K |
| 93976 |
|
1,328 |
1,225 |
$25K |
| 73110 |
|
845 |
777 |
$23K |
| 70486 |
|
297 |
261 |
$23K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
8,415 |
7,870 |
$23K |
| 74018 |
|
886 |
825 |
$20K |
| 93971 |
|
1,298 |
1,176 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,464 |
3,247 |
$19K |
| 71250 |
|
237 |
192 |
$19K |
| 76830 |
Ultrasound, transvaginal |
1,770 |
1,689 |
$18K |
| 84484 |
|
10,347 |
7,205 |
$18K |
| 85610 |
|
3,245 |
2,537 |
$18K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,002 |
745 |
$16K |
| 72131 |
|
361 |
308 |
$16K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,626 |
734 |
$16K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
199 |
174 |
$15K |
| 85730 |
|
2,693 |
2,090 |
$15K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
201 |
188 |
$15K |
| 84703 |
|
2,589 |
2,391 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,419 |
11,848 |
$12K |
| 73140 |
|
160 |
153 |
$11K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,954 |
2,418 |
$11K |
| 87807 |
|
1,487 |
1,450 |
$10K |
| 86900 |
|
1,762 |
1,529 |
$10K |
| C1769 |
Guide wire |
288 |
210 |
$10K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
132 |
68 |
$10K |
| 85014 |
|
849 |
739 |
$9K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,079 |
882 |
$9K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
507 |
416 |
$8K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
44 |
40 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,455 |
1,121 |
$7K |
| 85379 |
|
1,473 |
1,342 |
$7K |
| 73590 |
|
321 |
292 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,250 |
6,749 |
$7K |
| 86901 |
|
2,608 |
2,301 |
$6K |
| 80047 |
|
151 |
141 |
$6K |
| 73090 |
|
218 |
202 |
$6K |
| 80076 |
|
1,265 |
1,156 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,856 |
4,913 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,792 |
6,565 |
$5K |
| 73560 |
|
184 |
153 |
$5K |
| 73502 |
|
341 |
302 |
$5K |
| 64400 |
|
15 |
15 |
$5K |
| 83880 |
|
1,746 |
1,445 |
$4K |
| 73080 |
|
161 |
149 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
278 |
217 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,654 |
6,490 |
$3K |
| 82550 |
|
1,458 |
1,141 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,611 |
6,574 |
$3K |
| 29125 |
|
303 |
286 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,418 |
2,103 |
$3K |
| 73620 |
|
94 |
90 |
$3K |
| 83735 |
|
2,771 |
2,032 |
$3K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,587 |
1,347 |
$3K |
| 83690 |
|
8,685 |
7,552 |
$3K |
| 80061 |
Lipid panel |
1,165 |
948 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,538 |
5,541 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,341 |
1,201 |
$3K |
| 72100 |
|
192 |
177 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,837 |
5,174 |
$2K |
| 97162 |
|
60 |
45 |
$2K |
| 73100 |
|
65 |
60 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,003 |
523 |
$2K |
| 87205 |
|
74 |
55 |
$2K |
| 87040 |
|
1,677 |
1,204 |
$2K |
| J3490 |
Unclassified drugs |
17 |
13 |
$2K |
| 81015 |
|
119 |
110 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
1,067 |
476 |
$2K |
| 29515 |
|
29 |
25 |
$2K |
| 93017 |
|
90 |
80 |
$2K |
| 83605 |
|
1,858 |
1,491 |
$2K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
84 |
68 |
$2K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
21 |
18 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
17 |
17 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,370 |
2,115 |
$1K |
| 69200 |
|
14 |
14 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
54 |
48 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,449 |
3,983 |
$1K |
| 73700 |
|
14 |
13 |
$1K |
| 76775 |
|
16 |
12 |
$1K |
| 85018 |
|
1,021 |
894 |
$1K |
| 90714 |
|
1,501 |
1,382 |
$1K |
| 93970 |
|
142 |
131 |
$936.03 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
480 |
401 |
$826.98 |
| 84100 |
|
1,281 |
871 |
$826.82 |
| 84439 |
|
190 |
164 |
$762.74 |
| 72128 |
|
13 |
12 |
$642.53 |
| 80329 |
|
671 |
557 |
$599.31 |
| 80320 |
|
794 |
714 |
$548.92 |
| J2060 |
Injection, lorazepam, 2 mg |
1,460 |
1,116 |
$546.25 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
28 |
14 |
$535.35 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,590 |
1,412 |
$483.86 |
| 72141 |
|
15 |
13 |
$458.16 |
| 72110 |
|
25 |
24 |
$416.11 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,331 |
1,919 |
$414.17 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,664 |
1,303 |
$378.79 |
| 83615 |
|
267 |
229 |
$362.26 |
| 82248 |
|
489 |
369 |
$360.92 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
586 |
490 |
$345.50 |
| 76870 |
|
12 |
12 |
$307.71 |
| 82247 |
|
51 |
37 |
$288.72 |
| 84520 |
|
304 |
261 |
$280.13 |
| 87186 |
|
1,708 |
1,510 |
$222.60 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,234 |
1,140 |
$172.02 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
286 |
238 |
$171.66 |
| 86308 |
|
15 |
15 |
$164.26 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
293 |
270 |
$159.96 |
| 76820 |
|
234 |
101 |
$157.84 |
| J7050 |
Infusion, normal saline solution, 250 cc |
84 |
69 |
$156.30 |
| 96376 |
|
1,219 |
1,032 |
$155.55 |
| 97163 |
|
14 |
13 |
$154.56 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
252 |
182 |
$146.75 |
| 84550 |
|
272 |
234 |
$134.04 |
| 82607 |
|
37 |
25 |
$120.00 |
| 82746 |
|
37 |
25 |
$120.00 |
| 86140 |
|
198 |
181 |
$113.71 |
| 81002 |
|
33 |
29 |
$80.00 |
| 73120 |
|
29 |
25 |
$39.44 |
| 82570 |
|
96 |
81 |
$23.55 |
| 85652 |
|
46 |
37 |
$8.76 |
| J1630 |
Injection, haloperidol, up to 5 mg |
175 |
151 |
$7.40 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
36 |
32 |
$0.00 |
| 82077 |
|
32 |
29 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
45 |
36 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
12 |
12 |
$0.00 |
| 41899 |
Unlisted procedure, dentoalveolar structures |
77 |
75 |
$0.00 |
| 84450 |
|
105 |
88 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
3,613 |
3,440 |
$0.00 |
| 82010 |
|
39 |
32 |
$0.00 |
| 84460 |
|
106 |
89 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
60 |
58 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
17 |
12 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
76 |
54 |
$0.00 |
| 73070 |
|
25 |
24 |
$0.00 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
12 |
12 |
$0.00 |
| 82977 |
|
18 |
18 |
$0.00 |
| 85048 |
|
21 |
18 |
$0.00 |